Enanta Pharmaceuticals
ENTA
$8.10
Share price
0.87%
Change (1 day)
-47.30%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) - Net assets
Net assets on the balance sheet as of March 2025 : $93.53 Million USD
According to Enanta Pharmaceuticals
's latest financial reports the company has $93.53 Million USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-09-30 | $$0.12 B | -40.57% |
| 2023-09-30 | $$0.21 B | -32.55% |
| 2022-09-30 | $$0.32 B | -19.55% |
| 2021-09-30 | $$0.39 B | -12.33% |
| 2020-09-30 | $$0.45 B | -1.49% |
| 2019-09-30 | $$0.46 B | 17.48% |
| 2018-09-30 | $$0.39 B | 30.5% |
| 2017-09-30 | $$0.30 B | 11.76% |
| 2016-09-30 | $$0.26 B | 14.3% |
| 2015-09-30 | $$0.23 B | 58.86% |
| 2014-09-30 | $$0.14 B | 34.57% |
| 2013-09-30 | $$0.11 B | 151.47% |
| 2012-09-30 | $$43.92 M | 100.1% |
| 2011-09-30 | $$21.95 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | $1.46 B | 1,463.00% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $78.10 B | 83,405.10% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $16.49 B | 17,535.93% | 🇺🇸 USA |
 Merck MRK | $48.40 B | 51,643.68% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $17.44 B | 18,553.38% | 🇺🇸 USA |
 Novartis NVS | $38.45 B | 41,008.43% | 🇨🇭 Switzerland |